pyrroles has been researched along with Coxsackie Virus Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khedr, MA; Mohamed, MS; Nofal, S; Sayed, AI; Soror, SH | 1 |
| Wu, S; Zhang, A; Zhang, H | 1 |
| Dong, W; Guan, J; Liang, Y; Sun, X; Wang, G; Zhang, L; Zhu, J | 1 |
3 other study(ies) available for pyrroles and Coxsackie Virus Infections
| Article | Year |
|---|---|
Evaluation of novel pyrrolopyrimidine derivatives as antiviral against gastroenteric viral infections.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Coxsackievirus Infections; Enterovirus B, Human; Molecular Docking Simulation; Pyrimidines; Pyrroles; Rotavirus; Rotavirus Infections | 2019 |
Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis.
Topics: Animals; Atorvastatin; Blotting, Western; Connexin 43; Connexins; Coxsackievirus Infections; Cytokines; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunohistochemistry; Immunologic Factors; Interferon-gamma; Mice; Myocarditis; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Up-Regulation | 2010 |
Atorvastatin attenuates Coxsackie virus B3m-induced viral myocarditis in mice.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Atorvastatin; Coxsackievirus Infections; Fas Ligand Protein; fas Receptor; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Myocarditis; Myocardium; Pyrroles; RNA, Messenger; Troponin I | 2010 |